The Journal of Immunology, Vol 145, Issue 9 3054-3061, Copyright © 1990 by American Association of Immunologists

ARTICLES

Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells

V Patella, V Casolaro, L Bjorck and G Marone
Department of Medicine, University of Naples Federico II, Italy.

Peptostreptococcus magnus strain 312 (10(6) to 10(8)/ml), which synthesizes a protein capable of binding to kappa L chains of human Ig (protein L), stimulated the release of histamine from human basophils in vitro. P. magnus strain 644, which does not synthesize protein L, did not induce histamine secretion. Soluble protein L (3 x 10(-2) to 3 micrograms/ml) induced histamine release from human basophils. The characteristics of the release reaction were similar to those of rabbit IgG anti-Fc fragment of human IgE (anti-IgE): it was Ca2(+)- and temperature-dependent, optimal release occurring at 37 degrees C in the presence of 1.0 mM extracellular Ca2+. There was an excellent correlation (r = 0.82; p less than 0.001) between the maximal percent histamine release induced by protein L and that induced by anti-IgE, as well as between protein L and protein A from Staphylococcus aureus (r = 0.52; p less than 0.01). Preincubation of basophils with either protein L or anti-IgE resulted in complete cross-desensitization to a subsequent challenge with the heterologous stimulus. IgE purified from myeloma patients PS and PP (lambda-chains) blocked anti-IgE-induced histamine release but failed to block the histamine releasing activity of protein L. In contrast, IgE purified from myeloma patient ADZ (kappa- chains) blocked both anti-IgE- and protein L-induced releases, whereas human polyclonal IgG selectively blocked protein L-induced secretion. Protein L acted as a complete secretagogue, i.e., it activated basophils to release sulfidopeptide leukotriene C4 as well as histamine. Protein L (10(-1) to 3 micrograms/ml) also induced the release of preformed (histamine) and de novo synthesized mediators (leukotriene C4 and/or PGD2) from mast cells isolated from lung parenchyma and skin tissues. Intradermal injections of protein L (0.01 to 10 micrograms/ml) in nonallergic subjects caused a dose-dependent wheal-and-flare reaction. Protein L activates human basophils and mast cells in vitro and in vivo presumably by interacting with kappa L chains of the IgE isotype.

This article has been cited by other articles:

				E. Calderon, E. Carter, K. M. Ramsey, J. A. Vande Waa, W. K. Green, and M. A. Alpert Necrotizing Fasciitis: A Complication of Percutaneous Coronary Revascularization Angiology, June 1, 2007; 58(3): 360 - 366. [Abstract] [PDF]

				A. L. Anderson, R. Sporici, J. Lambris, D. LaRosa, and A. I. Levinson Pathogenesis of B-Cell Superantigen-Induced Immune Complex-Mediated Inflammation Infect. Immun., February 1, 2006; 74(2): 1196 - 1203. [Abstract] [Full Text] [PDF]

				M. Viau, N. S. Longo, P. E. Lipsky, L. Bjorck, and M. Zouali Specific In Vivo Deletion of B-Cell Subpopulations Expressing Human Immunoglobulins by the B-Cell Superantigen Protein L Infect. Immun., June 1, 2004; 72(6): 3515 - 3523. [Abstract] [Full Text] [PDF]

				N. G. Housden, S. Harrison, H. R. Housden, K.-A. Thomas, J. A. Beckingham, S. E. Roberts, S. P. Bottomley, M. Graille, E. Stura, and M. G. Gore Observation and Characterization of the Interaction between a Single Immunoglobulin Binding Domain of Protein L and Two Equivalents of Human {kappa} Light Chains J. Biol. Chem., March 5, 2004; 279(10): 9370 - 9378. [Abstract] [Full Text] [PDF]

				A. Genovese, G. Borgia, L. Bjorck, A. Petraroli, A. de Paulis, M. Piazza, and G. Marone Immunoglobulin Superantigen Protein L Induces IL-4 and IL-13 Secretion from Human Fc{varepsilon}RI+ Cells Through Interaction with the {kappa} Light Chains of IgE J. Immunol., February 15, 2003; 170(4): 1854 - 1861. [Abstract] [Full Text] [PDF]

				A. Genovese, J.-P. Bouvet, G. Florio, B. Lamparter-Schummert, L. Bjorck, and G. Marone Bacterial Immunoglobulin Superantigen Proteins A and L Activate Human Heart Mast Cells by Interacting with Immunoglobulin E Infect. Immun., October 1, 2000; 68(10): 5517 - 5524. [Abstract] [Full Text] [PDF]

				W. W. Navarre and O. Schneewind Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope Microbiol. Mol. Biol. Rev., March 1, 1999; 63(1): 174 - 229. [Abstract] [Full Text] [PDF]

				L. M. Kozlowski, W. Li, M. Goldschmidt, and A. I. Levinson In Vivo Inflammatory Response to a Prototypic B Cell Superantigen: Elicitation of an Arthus Reaction by Staphylococcal Protein A J. Immunol., June 1, 1998; 160(11): 5246 - 5252. [Abstract] [Full Text] [PDF]

				D. A. Murdoch Gram-Positive Anaerobic Cocci Clin. Microbiol. Rev., January 1, 1998; 11(1): 81 - 120. [Abstract] [Full Text] [PDF]

				M. de Chateau, E. Holst, and L. Bjorck Protein PAB, an Albumin-binding Bacterial Surface Protein Promoting Growth and Virulence J. Biol. Chem., October 25, 1996; 271(43): 26609 - 26615. [Abstract] [Full Text] [PDF]